Lung cancer screening: making the transition from research to clinical practice
Current Opinion in Pulmonary Medicine, 06/01/2012Grosu HB et al.
There is now evidence that low–dose computed tomography (LDCT) in carefully selected high–risk populations can lead to better outcomes but the cost effectiveness of mass screening with LDCT is still unknown. Only patients at high risk for cancer should be screened.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.